ID
35198
Beschrijving
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the results of the subjects laboratory tests and should be filled out at Visit 1, 6 (liver tests only) , 8, EW, Day 7 Follow Up, Day 14 Follow Up. Laboratory tests are mandatory at Day 7 FU visit except where Day 7 FU follows Early Withdrawal Visit.
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Trefwoorden
Versies (2)
- 24-02-19 24-02-19 -
- 10-11-19 10-11-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
24 februari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Laboratory Tests
- StudyEvent: ODM
Beschrijving
Haematology
Alias
- UMLS CUI-1
- C0018941
Beschrijving
Clinical Chemistry
Alias
- UMLS CUI-1
- C0008000
Beschrijving
Urinalysis
Alias
- UMLS CUI-1
- C0042014
Similar models
Laboratory Tests
- StudyEvent: ODM
C2985720 (UMLS CUI [1,2])